Forty Seven Inc.
Gilead Sciences is committed to creating a healthier world through innovation and science. With a focus on therapeutic areas such as virology, oncology, and inflammation, Gilead develops and delivers transformative therapies. The company emphasizes health equity, inclusion, and community impact, with a global workforce dedicated to improving lives and advancing public health.
Industries
Nr. of Employees
small (1-50)
Forty Seven Inc.
333 Lakeside Drive, Foster City, CA 94404
Patents
Dosing parameters for CD47 targeting therapies to hematologic malignancies
US-12274746-B2
View DetailsDosing parameters for CD47 targeting therapies to hematologic malignancies
US-12194093-B2
View Details
Dosing parameters for CD47 targeting therapies to hematologic malignancies
US-12274746-B2
View DetailsDosing parameters for CD47 targeting therapies to hematologic malignancies
US-12194093-B2
View DetailsProducts
Yeztugo (lenacapavir) injection
An approved long-acting injectable formulation of lenacapavir for HIV prevention delivered as an intramuscular injection.
Trodelvy (sacituzumab govitecan) for injection
An antibody–drug conjugate indicated for certain oncology indications and studied in first-line metastatic triple-negative breast cancer.
Yescarta (axicabtagene ciloleucel)
An autologous CAR T-cell therapy for certain hematologic malignancies.
Veklury (remdesivir) for injection
An antiviral small-molecule formulation for intravenous administration developed and deployed during the COVID-19 response.
Harvoni / Sovaldi (sofosbuvir-based regimens)
Oral direct-acting antiviral regimens for treatment of chronic hepatitis C.
Yeztugo (lenacapavir) injection
An approved long-acting injectable formulation of lenacapavir for HIV prevention delivered as an intramuscular injection.
Trodelvy (sacituzumab govitecan) for injection
An antibody–drug conjugate indicated for certain oncology indications and studied in first-line metastatic triple-negative breast cancer.
Yescarta (axicabtagene ciloleucel)
An autologous CAR T-cell therapy for certain hematologic malignancies.
Veklury (remdesivir) for injection
An antiviral small-molecule formulation for intravenous administration developed and deployed during the COVID-19 response.
Harvoni / Sovaldi (sofosbuvir-based regimens)
Oral direct-acting antiviral regimens for treatment of chronic hepatitis C.
Services
Programs to expand patient access to therapies, including medication access initiatives, authorized distributor management and patient-reimbursement assistance.
Competitive grants and investigator funding to support biomedical and translational research in targeted therapeutic areas.
Clinical trial sites and operational support for multicenter studies, including pediatric trials and long-term extension study opportunities.
Centralized medical information services and adverse event/product complaint handling for marketed and investigational products.
Collaborative research agreements, option and license arrangements with industry and academic partners to advance novel programs and technologies.
Programs to expand patient access to therapies, including medication access initiatives, authorized distributor management and patient-reimbursement assistance.
Competitive grants and investigator funding to support biomedical and translational research in targeted therapeutic areas.
Clinical trial sites and operational support for multicenter studies, including pediatric trials and long-term extension study opportunities.
Centralized medical information services and adverse event/product complaint handling for marketed and investigational products.
Collaborative research agreements, option and license arrangements with industry and academic partners to advance novel programs and technologies.
Expertise Areas
- Clinical trial management
- Clinical pipeline and program management
- Virology drug development
- Oncology drug development, including cell therapy
Key Technologies
- Cell therapy (CAR T)
- Small-molecule therapeutics
- Targeted protein degraders
- Long-acting injectable formulation technologies